Cancer discovery news
Our researchers are making the discoveries that defeat cancer. Read the latest findings from our world-leading research.
Visit our main news hub to read about news on new funding, our fundraising activities and much more. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Cancer treatment progress: Two promising new drugs revealed
Scientists at The Institute of Cancer Research have this week revealed promising early results from two exciting new targeted cancer drug
Drug’s ‘double hit’ overcomes leukaemia resistance
A drug that uses a unique ‘double hit’ to kill leukaemia cells could be a potential new treatment for patients with acute myeloid leukaemia. The research, led by the ICR, is published today in the journal Leukaemia.
Scientists develop new strategy to overcome drug-resistant childhood cancer
A new drug combination could offer hope to children with neuroblastoma – one of the deadliest forms of childhood cancer – by boosting the effectiveness of a promising new gene-targeted treatment.
'Master switch' experimental drug could treat different cancers
A unique multi-target experimental drug could treat a range of cancer types, according to research led by the ICR and published in Clinical Cancer Research today.
Pan-European project aims to screen patients for hidden cancer cells
Scientists across Europe are to collaborate on a €6m project to develop a technique of screening a patient’s entire blood volume for cancer cells that have evaded treatment.
Cancer drug discoverer honoured with global entrepreneurship award
Professor Paul Workman has won a global award recognising his success at taking pioneering drugs out of the laboratory and into commercial development for the ultimate benefit of patients worldwide.
New way to control cancer blood supply discovered
An entirely new way to control the development of blood vessels has been discovered by scientists, which could lead to improved treatment of cancer, heart disease and eye disease, with fewer side effects. The results are published today in the journal Blood.
More UK men given access to abiraterone
Even more men are set to benefit from the prostate cancer drug abiraterone after it was approved for NHS use in Northern Ireland.
Landmark study describes long-term risk of breast cancer from lymphoma treatment
New research from the ICR identifies the personalised breast cancer risk for women treated for Hodgkin lymphoma.
‘Hitch-hiking’ viral therapy deals a double blow to cancer
Scientists have shown how a promising viral therapy that delivers a double blow to cancer can sneak up on tumours undetected by hitching a ride on blood cells.
Abiraterone acetate shows success in earlier-stage prostate cancer patients
A large-scale international trial has shown that the ICR-discovered drug abiraterone acetate can benefit patients with earlier-stage prostate cancer, according to results being presented at the ASCO annual meeting today.
Prostate cancer drug shown to extend life and improve quality of life
The drug enzalutamide has been shown to extend life for men with advanced prostate cancer and offers improved quality of life, according to new data from a Phase III clinical trial jointly led by the ICR and The Royal Marsden.